支气管扩张症急性加重期患者的病原菌药敏分析

目的探讨支气管扩张症急性加重期患者的病原菌药敏情况。方法对该院收治的64例支气管扩张症急性加重期患者的的痰细菌药敏结果进行回顾性分析。结果 64例患者中,培养阳性34例,铜绿假单胞菌18株,大肠埃希氏菌4株,肺炎克雷伯杆菌4株;铜绿假单胞菌的药敏结果中,对头孢哌酮/舒巴坦、哌拉西林/他唑巴坦、碳氢霉烯类抗生素等敏感性较高。结论支气管扩张症急性加重期患者针对性选择细菌敏感的抗菌药物,减少耐药菌的产生。

Analysis of Antibiotic Susceptibility of the Patients with Acute Exacerbating Bronchiectasis

Objective To analyse the bacterial drug resistance of the patients with acute exacerbations of bronchiectasis. Methods We performed a retrospective investigation ,64 patients with acute exacerbations of bronchiectasis ,who were hospitalized in 2009～2012 carried on the analysis of sputum bacterial drug sensitive experiment. Results The sputum bacterial cultivation positive 34 cases among the 64 bronchiectasis patients, Pseudomonas aeruginosa strain 18 , Escherichia coli 4 strains ,Klebsiella pneumonia in 4 strains .In response to Pseudomonas aeruginosa susceptibility results, to Cefoperazone / sulbactam, piperacillin / tazobactam, hydrocarbon of carbapenem antibiotics such as higher sensitivity. Conclusion It should be targeted to choose their sensitive antibiotics for patients with acute exacerbation, reduce the emergence of resistant bacteria.